Market Research Reports, Inc.

Drug Eluting Stent Market in China to grow at a CAGR of 10.70% during 2014 - 2019; Finds New Report

Market Research Reports, Inc. has announced the addition of “Drug Eluting Stent Market in China - Industry Research Report 2015-2019” research report to their website


Lewes, DE -- (SBWIRE) -- 10/14/2015 -- Report forecast the drug eluting stent market in China to grow at a CAGR of 10.70% over the period 2014-2019.

Drug eluting stent, also known as medicated coronary stent, is a tiny, expandable metal mesh tube that is covered with a pharmacologic agent. It prevents artery blockages in patients after angioplasty. It also eliminates the need for repeated revascularization procedures that are used to treat restenosis (narrowing of blood vessels).

This report covers the present and future scenario of the drug eluting stent market in China for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of drug eluting stents.

Drug Eluting Stent Market in China 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the drug eluting stent market in China and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

According to the report, increased workload, physical inactivity, and unhealthy diet lead to high blood glucose, blood pressure, and accumulation of lipids that cause hypertension, obesity, abnormal cholesterol, and diabetic problems in individuals. These factors result in cardiac disorders, which is also prevalent among the elderly aged 65 and above. In the recent years, incidences of CVDs such as stroke, myocardial infarction, and CHDs have increased.

Key players in the Drug Eluting Stent Market in China: MicroPort Scientific, Lepu Medical, Shandong JW Medical Systems, Abbott Vascular and Medtronic

Other Prominent Vendors in the market are: Boston Scientific, Biosensors International, Cook Medical, Opto Circuit, QualiMed, Sinomed, and Terumo Medical.

Market driver
- High prevalence of CVDs
- For a full, detailed list, view our report

Market challenge
- Availability of alternative coronary stents
- For a full, detailed list, view our report

Market trend
- Increase in demand for minimally-invasive procedures
- For a full, detailed list, view our report

Key questions answered in this report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 56 pages "Drug Eluting Stent Market in China - Industry Research Report 2015-2019" report covers Executive Summary, Scope of the Report, Market Research Methodology, Introduction, Stents: An overview, Market landscape, Healthcare reform in China, Opportunities for global and local vendors, Market drivers, Impact of drivers, Market challenges, Impact of drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

For further information on this report, please visit-

Related Reports:

Global Preventive Asthma Drugs Market 2015-2019 - visit at:

Clinical Diagnostics Market in APAC - Market Analysis 2015-2019 - visit at:

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

Yearly/Quarterly Report Subscription: